At the Sharda Hospital in Greater Noida near New Delhi, pharma student Khushi Dhingra, 17, hugged a friend and wept as she waited to get her shot. "I am very afraid. I hate needles and I am worried about side effects," she told AFP. "My papa is very worried too. He is calling me again and again to make sure I am okay." "There are about 80 students in my batch but only two have opted to get the shot," said nursing student Sakshi Sharma, 21, in Greater Noida. "My friends are saying there will be side effects, that you can even get paralysis." India is using two shots for its drive. One is Covishield, a locally produced version of the Oxford-AstraZeneca vaccine, which has been approved and safely used in a number of other countries after completing Phase 3 human trials. The other -- Covaxin -- was developed locally by Bharat Biotech and has not yet completed Phase 3 trials, though the government has insisted it is "110 percent safe". - WhatsApp worries - Side effects are a common … [Read more...] about Tears and fears as India’s huge coronavirus vaccine push falters
90 estimated tax payment
Bao Minh Insurance plans to divest from MBB
In the third quarter, MBB reported an increase of 6.1 per cent year-on-year to more than VND6,735 trillion in revenue. The bank’s profit after tax rose 8.3 per cent to VND2.357 trillion. In the first nine months of last year, the profit after tax climbed 6.4 per cent year-on-year to nearly VND6.332 trillion. … [Read more...] about Bao Minh Insurance plans to divest from MBB
HCMC metro consultant asked to conduct personnel review after breach of contract
Earlier this month, a team of independent inspectors found another pad had moved from its position on the elevated section and does not fit properly. Around half the pads used were made in Malaysia and imported from South Korea. The rest were made in Japan. … [Read more...] about HCMC metro consultant asked to conduct personnel review after breach of contract